Np mrd loader

Record Information
Version2.0
Created at2024-09-10 18:56:00 UTC
Updated at2024-09-10 18:56:00 UTC
NP-MRD IDNP0334566
Secondary Accession NumbersNone
Natural Product Identification
Common NameTopiramate
DescriptionTopiramate, also known as topamax or MCN-4853, belongs to the class of organic compounds known as dioxolopyrans. Dioxolopyrans are compounds containing a dioxolopyran moiety, which consists of a dioxole ring fused to a pyran ring. Topiramate is an extremely weak basic (essentially neutral) compound (based on its pKa). Topiramate is a bitter tasting compound. Outside of the human body,. It was first documented in 1999 (PMID: 10025774). Topiramate is a potentially toxic compound (PMID: 19212411) (PMID: 22233396) (PMID: 22249827).
Structure
Thumb
Synonyms
ValueSource
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamateChEBI
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamateChEBI
MCN-4853ChEBI
RWJ-17021ChEBI
TipiramateChEBI
TipiramatoChEBI
TopamaxChEBI
TopiramatoChEBI
TopiramatumChEBI
TPMChEBI
Trokendi XRKegg
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamateGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamateGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acidGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamateGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acidGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamateGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamateGenerator
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acidGenerator
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamateGenerator
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamateGenerator
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acidGenerator
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamateGenerator
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acidGenerator
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamateGenerator
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acidGenerator
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamateGenerator
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acidGenerator
Tipiramic acidGenerator
Topiramic acidGenerator
EpitomaxHMDB
Topamax sprinkleHMDB
TopomaxHMDB
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamateHMDB
Chemical FormulaC12H21NO8S
Average Mass339.3620 Da
Monoisotopic Mass339.09879 Da
IUPAC Name[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0²,⁶]dodecan-6-yl]methyl sulfamate
Traditional Nametopiramate
CAS Registry NumberNot Available
SMILES
[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2
InChI Identifier
InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1
InChI KeyKJADKKWYZYXHBB-XBWDGYHZSA-N
Experimental Spectra
Not Available
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dioxolopyrans. Dioxolopyrans are compounds containing a dioxolopyran moiety, which consists of a dioxole ring fused to a pyran ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDioxolopyrans
Sub ClassNot Available
Direct ParentDioxolopyrans
Alternative Parents
Substituents
  • Dioxolopyran
  • Ketal
  • Oxane
  • Monosaccharide
  • Organic sulfuric acid or derivatives
  • Meta-dioxolane
  • Oxacycle
  • Acetal
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP1.29ALOGPS
logP0.13ChemAxon
logS-1.7ALOGPS
pKa (Strongest Acidic)11.09ChemAxon
pKa (Strongest Basic)-3.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area115.54 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity72.3 m³·mol⁻¹ChemAxon
Polarizability32.42 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDHMDB0005034
DrugBank IDDB00273
Phenol Explorer Compound IDNot Available
FoodDB IDFDB023601
KNApSAcK IDNot Available
Chemspider ID4447672
KEGG Compound IDC07502
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkTopiramate
METLIN IDNot Available
PubChem Compound5284627
PDB IDTOR
ChEBI ID63631
Good Scents IDNot Available
References
General References
  1. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
  2. Petroff OA, Hyder F, Mattson RH, Rothman DL: Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology. 1999 Feb;52(3):473-8. [PubMed:10025774 ]
  3. Luo N, Di W, Zhang A, Wang Y, Ding M, Qi W, Zhu Y, Massing MW, Fang Y: A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Pain Med. 2012 Jan;13(1):80-6. doi: 10.1111/j.1526-4637.2011.01295.x. [PubMed:22233396 ]
  4. Antel J, Hebebrand J: Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide. Handb Exp Pharmacol. 2012;(209):433-66. doi: 10.1007/978-3-642-24716-3_20. [PubMed:22249827 ]